Detalhe da pesquisa
1.
e-Lung Computed Tomography Biomarker Stratifies Patients at Risk of Idiopathic Pulmonary Fibrosis Progression in a 52-Week Clinical Trial.
Am J Respir Crit Care Med
; 209(9): 1168-1169, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38363798